[Catecholaminergic polymorphic ventricular tachycardia is a rare inherited heart disease.]
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
[Catecholaminergic polymorphic ventricular tachycardia is a rare inherited heart disease.]. / Holst, Anders Gaarsdal; Tfelt-Hansen, 1jacob; Olesen, Morten S; Theilade, Juliane; Winkel, Bo G; Christensen, Alex H; Bundgaard, Henning; Haunsø, Stig; Svendsen, Jesper Hastrup.
I: Ugeskrift for læger, Bind 172, Nr. 31, 2010, s. 2140-2144.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - [Catecholaminergic polymorphic ventricular tachycardia is a rare inherited heart disease.]
AU - Holst, Anders Gaarsdal
AU - Tfelt-Hansen, 1jacob
AU - Olesen, Morten S
AU - Theilade, Juliane
AU - Winkel, Bo G
AU - Christensen, Alex H
AU - Bundgaard, Henning
AU - Haunsø, Stig
AU - Svendsen, Jesper Hastrup
PY - 2010
Y1 - 2010
N2 - Catecholaminergic polymorphic ventricular tachycardia is a rare inherited heart disease, which can lead to life-threatening ventricular arrhythmias in patients with a structurally normal heart. The age of onset is usually between two and 12 years and the initial symptom is frequently syncope or cardiac arrest. The arrhythmias are usually triggered by exercise or emotional affection. The diagnosis is often made using exercise electrocardiogram, which typically triggers arrhythmias. The treatment consists of beta blockers, frequently in combination with implantation of a cardioverter-defibrillator. Udgivelsesdato: 2010-Aug
AB - Catecholaminergic polymorphic ventricular tachycardia is a rare inherited heart disease, which can lead to life-threatening ventricular arrhythmias in patients with a structurally normal heart. The age of onset is usually between two and 12 years and the initial symptom is frequently syncope or cardiac arrest. The arrhythmias are usually triggered by exercise or emotional affection. The diagnosis is often made using exercise electrocardiogram, which typically triggers arrhythmias. The treatment consists of beta blockers, frequently in combination with implantation of a cardioverter-defibrillator. Udgivelsesdato: 2010-Aug
M3 - Tidsskriftartikel
C2 - 20670590
VL - 172
SP - 2140
EP - 2144
JO - Ugeskrift for Laeger
JF - Ugeskrift for Laeger
SN - 0041-5782
IS - 31
ER -
ID: 21258694